tiprankstipranks
Advertisement
Advertisement
Teva presents positive long-term study data for Austedo
PremiumThe FlyTeva presents positive long-term study data for Austedo
13d ago
Alvotech announces FDA acceptance of AVT16 BLA for review
Premium
The Fly
Alvotech announces FDA acceptance of AVT16 BLA for review
13d ago
Teva announces new data on AUSTEDO tablets, AUSTEDO XR tablets
Premium
The Fly
Teva announces new data on AUSTEDO tablets, AUSTEDO XR tablets
16d ago
Teva commits to Veeva Vault CRM
PremiumThe FlyTeva commits to Veeva Vault CRM
25d ago
Teva announces EMA acceptance of MAA for olanzapine long-acting injectable
Premium
The Fly
Teva announces EMA acceptance of MAA for olanzapine long-acting injectable
1M ago
Einhorn’s DME takes stakes in StubHub, Paramount, buys more Peloton
Premium
The Fly
Einhorn’s DME takes stakes in StubHub, Paramount, buys more Peloton
1M ago
Teva price target raised to $50 from $45 at Goldman Sachs
PremiumThe FlyTeva price target raised to $50 from $45 at Goldman Sachs
2M ago
Teva price target raised to $40 from $35 at JPMorgan
Premium
The Fly
Teva price target raised to $40 from $35 at JPMorgan
2M ago
Teva price target raised to $42 from $41 at Piper Sandler
Premium
The Fly
Teva price target raised to $42 from $41 at Piper Sandler
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100